IRIS Institutional Research Information System - OPENBS Open Archive UniBS

METRA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 94.094
AS - Asia 59.157
EU - Europa 47.093
SA - Sud America 12.472
Continente sconosciuto - Info sul continente non disponibili 2.071
AF - Africa 1.343
OC - Oceania 127
AN - Antartide 2
Totale 216.359
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 92.076
SG - Singapore 19.511
CN - Cina 19.186
UA - Ucraina 10.951
BR - Brasile 10.466
IT - Italia 8.090
HK - Hong Kong 7.849
RU - Federazione Russa 5.407
DE - Germania 5.196
PL - Polonia 3.687
FR - Francia 3.622
VN - Vietnam 3.443
FI - Finlandia 3.072
GB - Regno Unito 2.622
TR - Turchia 2.356
IN - India 2.135
IE - Irlanda 1.969
BD - Bangladesh 1.724
CA - Canada 897
AR - Argentina 753
SE - Svezia 715
MX - Messico 554
IQ - Iraq 491
NL - Olanda 385
ID - Indonesia 369
ZA - Sudafrica 359
EC - Ecuador 330
JP - Giappone 286
SA - Arabia Saudita 263
AT - Austria 257
PK - Pakistan 250
CO - Colombia 228
ES - Italia 227
VE - Venezuela 186
MA - Marocco 173
NG - Nigeria 164
UZ - Uzbekistan 155
PY - Paraguay 153
KE - Kenya 151
CL - Cile 136
CZ - Repubblica Ceca 136
BE - Belgio 131
JM - Giamaica 121
QA - Qatar 119
AU - Australia 115
EG - Egitto 105
TN - Tunisia 103
AE - Emirati Arabi Uniti 92
PE - Perù 90
MU - Mauritius 86
JO - Giordania 85
PH - Filippine 82
NP - Nepal 81
UY - Uruguay 81
EU - Europa 76
CR - Costa Rica 70
IL - Israele 70
MY - Malesia 66
HN - Honduras 65
RO - Romania 65
LT - Lituania 60
TT - Trinidad e Tobago 60
AZ - Azerbaigian 54
IR - Iran 54
KR - Corea 54
CH - Svizzera 53
DZ - Algeria 50
KZ - Kazakistan 50
AL - Albania 48
PA - Panama 48
EE - Estonia 47
ET - Etiopia 47
OM - Oman 42
DO - Repubblica Dominicana 41
MD - Moldavia 39
BO - Bolivia 38
LB - Libano 36
TH - Thailandia 36
TW - Taiwan 35
PT - Portogallo 34
NO - Norvegia 33
SV - El Salvador 33
BG - Bulgaria 32
NI - Nicaragua 30
PS - Palestinian Territory 30
HU - Ungheria 28
SN - Senegal 28
GR - Grecia 26
LV - Lettonia 25
SC - Seychelles 25
GT - Guatemala 23
RS - Serbia 23
BH - Bahrain 22
KG - Kirghizistan 22
SK - Slovacchia (Repubblica Slovacca) 20
BB - Barbados 19
SY - Repubblica araba siriana 18
DK - Danimarca 17
MK - Macedonia 15
PR - Porto Rico 14
Totale 214.092
Salva come PNG Salva come JPEG
Città #
Singapore 10.040
Fairfield 8.130
Jacksonville 8.014
Hong Kong 7.806
Ashburn 7.219
Woodbridge 6.027
Houston 4.235
Chandler 4.080
Moscow 4.056
Beijing 3.783
The Dalles 3.770
San Jose 3.714
Warsaw 3.612
Cambridge 3.592
Princeton 3.521
Wilmington 3.445
Ann Arbor 3.254
Seattle 3.130
Nanjing 2.769
New York 2.396
Council Bluffs 2.078
Dublin 1.949
Lauterbourg 1.883
Istanbul 1.843
Columbus 1.661
Los Angeles 1.623
Helsinki 1.505
Ho Chi Minh City 1.223
Nanchang 1.039
Milan 1.005
Buffalo 984
São Paulo 876
Des Moines 827
Shenyang 684
Hanoi 670
Hebei 661
Redondo Beach 626
Dallas 621
Changsha 615
Tianjin 544
Munich 526
San Diego 521
Santa Clara 495
Brescia 480
Jiaxing 458
Rome 438
Chicago 435
Shanghai 430
Jinan 411
Dearborn 378
Orem 366
San Francisco 359
London 351
Rio de Janeiro 340
Boardman 330
Hangzhou 327
Kunming 322
Frankfurt am Main 300
Kocaeli 247
Tokyo 246
Verona 244
Nuremberg 243
Chennai 241
Belo Horizonte 236
Brooklyn 229
Toronto 228
Guangzhou 222
Phoenix 222
Romola 221
Mexico City 209
Atlanta 202
Montreal 201
Zhengzhou 197
Brasília 172
Turku 171
Lancaster 167
Johannesburg 159
Curitiba 158
Boston 148
Lappeenranta 148
Pune 148
Abuja 146
Dhaka 145
Denver 144
Ningbo 140
Tashkent 140
Porto Alegre 138
Lanzhou 134
Baghdad 132
Haiphong 132
Da Nang 131
Manchester 131
Charlotte 126
Naples 126
Salvador 126
Nairobi 125
Stockholm 121
Dong Ket 120
Doha 119
Amsterdam 115
Totale 133.927
Salva come PNG Salva come JPEG
Nome #
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis 3.381
Un caso di Sindrome di Bland-White-Garland: origine anomala dell’arteria coronaria sinistra dall’arteria polmonare. 730
Effect of nesiritide in patients with acute decompensated heart failure. 536
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 495
American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). 432
Inodilatatori: perché e quali. 410
Farmaci inotropi non digitalici. 389
La cardiomioplastica dinamica come trattamento della cardiomiopatia dilatativa ingravescente. 376
Livelli circolanti del marcatore tumorale CA 125 in pazienti con scompenso cardiaco cronico:relazione con la classe NYHA, i parametri ecocardiografici e variazioni indotte dalla terapia. 375
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. 352
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European society of cardiology and endorsed by the European society of intensive care medicine 347
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial 346
Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance 344
Il genotipo DD per il gene dell’enzima di conversione dell’angiotensina identifica i pazienti con insufficienza cardiaca che possono beneficiare di dosi medio elevate di ACE inibitori. 343
Can we improve the treatment of congestion in heart failure? 311
Impact of serial troponin release on outcomes in patients with acute heart failure: Analysis from the protect pilot study 298
Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. 296
The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure 292
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. 284
Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. 283
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. 272
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure 271
Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study 264
Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow? 261
Old and new intravenous inotropic agents in the treatment of advanced heart failure 260
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. 260
I polimorfismi Arg16Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca 259
Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET. 258
Troponin T levels in patients with acute heart failure : clinical and prognostic significance of their delection and release during hospitalisation 255
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study 247
L’ indice di performance miocardica ( MPI ) è un importante indicatore prognostico nei pazienti affetti da insufficienza cardiaca cronica. 241
May 2020 at a glance: ischaemic heart failure and sex-related differences 241
Postdischarge assessment after a heart failure hospitalization: the next step forward. 237
I polimorfismi Arg16 Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca. 235
[West Nile virus and myocarditis, a rare event: case report] 233
Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release. 231
Highlights of the 2009 scientific sessions of the European Society of Cardiology. 228
Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial. 227
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study 224
Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol. 222
Sindromi coronariche acute: ruolo dell’infezione cronica da Helicobacter Pylori e Citomegalovirus. 219
Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF. 219
Effects of serelaxin in patients with acute heart failure 219
Characteristics and mid-term follow-up of a single-center population affected by Tako-Tsubo cardiomyopathy 214
Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Societyof Cardiology 211
Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents. 210
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: A long-term comparison 209
Effects of the Adenosine A(1) Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure an Renal Dysfunction Results From PROTECT (Placebo-Controlled Randomized Study of the Selective A(1) Adenosine ReceptorAntagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function) 209
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 208
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 205
Acute and chronic effects of the dihydropyridine calcium antagonist nisoldipine on the resting and exercise hemodynamics, neurohumoral parameters, and functional capacity of patients with chronic heart failure. 202
Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience 201
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. 200
Task Force sullo Scompenso Cardiaco Acuto della Societa Europea di Cardiologia. Versione italiana a cura di A Gavazzi, M Metra. Riassunto esecutivo delle linee guida sulla diagnosi e trattamento dello scompenso cardiaco acuto. 199
Clinical trials update from the World Congress of Cardiology 2006. 199
Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction 197
Global epidemiology of heart failure 196
Fattori di rischio ed “epidemiologia inversa” nei pazienti con insufficienza cardiaca. 196
A randomized double-blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant essential hypertension. 196
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 196
Efficacia di un nuovo diuretico, la muzolimina, in pazienti con insufficienza cardiaca. 195
The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. 194
Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion? 193
Determinazione dell’equilibrio simpato-vagale attraverso l’analisi spettrale della variabilità della frequenza cardiaca in pazienti con insufficienza cardiaca di diverso grado di severità. 192
Effetti cardiovascolari della ventilazione servo-adattativa (ASV) in pazienti affetti da apnee notturne e scompenso cardiaco cronico con disfunzione sistolica ventricolare sinistra 191
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 189
A case of iatrogenic severe mitral regurgitation 188
Self-expanding transcatheter aortic valve implantation for degenerated small Mitroflow bioprosthesis: Early and midterm outcomes 187
Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: preliminary results 186
Amino acids and derivatives, a new treatment of chronic heart failure? 186
2024 update in heart failure 183
A drastic complex atheromatous aorta. A case report. 183
Effectiveness of MitraClip therapy in patients with refractory heart failure 183
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 182
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 179
Can we prevent or treat renal dysfunction in acute heart failure? 178
Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients 177
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 177
An unusual case of myocardial infarction 176
Neurohormonal activation in acute heart failure: results from VERITAS 175
Clinical Presentation and Outcome in a Contemporary Cohort of Patients with Acute Myocarditis: The Multicenter Lombardy Registry 175
A rationale for the use of BETA-blockers as standard treatment for heart failure 174
Are Beta-1 and alpha2c-adrenergic receptor polymorphisms associated with an increased risk of heart failure in Caucasian subjects: results of a case-control study 174
ESC Committe for Practice Guideline (CPG). Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. 174
Agents with vasodilator properties in acute heart failure: how to design successful trials 174
Acute hemodynamic effects of the two dopaminergic agonists ibopamine and dihydroergotamine, a comparison with the parent compound. 172
Beta- adrenergic receptors polymorphisms and response to CRT 171
January 2017 at a glance: oncology, diabetes and antidiabetic treatment, pulmonary hypertension 171
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 170
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 169
Effect of High dose of atorvastatin versus moderate dose on endothelial function and inflammatory biomarkers in patients with STEMI 167
EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot) 167
Hyponatremia and long-term outcomes in chronic heart failure--an observational study from the Duke Databank for Cardiovascular Diseases. 166
Low Lymphocyte Ratio as a Novel Prognostic Factor in Acute HeartFailure: Results from the Pre-RELAX-AHF Study. 165
Heart failure in elderly patients: distinctive features and unresolved issues 165
A randomized double blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant hypertension. Ca+ Nicardipine. Selected reports from the worldwide literature. 164
1Beta-2 adrenergic receptors gene polymorphisms influence the effects of carvedilol in the patients with heart failure. 164
The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T 164
Raised homocystein plasma concentration in patients with heart failure: Clinical significance 163
Different types of tricuspid flail: Case reports and review of the literature 163
Totale 26.717
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.145.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.145.850
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211.075 0 2.281 230 766 247 621 378 981 646 1.315 1.114 2.496
2022/202312.157 1.997 251 132 995 1.079 3.563 47 1.195 1.745 107 505 541
2023/202412.855 752 279 742 837 523 1.817 460 472 3.495 340 741 2.397
2024/202533.663 983 971 811 3.719 3.830 2.485 2.772 1.475 2.820 2.920 6.446 4.431
2025/202663.877 5.959 9.470 5.066 9.586 4.792 3.839 8.793 2.945 4.027 5.462 2.489 1.449
2026/20275.985 3.385 2.600 0 0 0 0 0 0 0 0 0 0
Totale 216.359